A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

Inclusion Criteria: * Healthy adult men and women, ages 19-45 * Non smokers Exclusion Criteria: * History of a bleeding disorder * Use of any drug known to have an effect on coagulation or clotting or any anti-platelet therapy within 2 weeks of the screening * Recently donated blood or had significant blood loss * Current use of a prescription medication * Pregnant females